XML 100 R53.htm IDEA: XBRL DOCUMENT v3.19.3
Restatement of Previously Issued Condensed Consolidated Financial Statements Schedule of Restatement of Consolidated Statement of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 28, 2019
Sep. 29, 2018
Sep. 28, 2019
Sep. 29, 2018
Consolidated Statements of Cash Flows        
Net income/(loss) $ 898 $ 618 $ 1,750 $ 2,374
Depreciation and amortization     737 712
Amortization of postretirement benefit plans prior service costs/(credits)     (229) (261)
Equity award compensation expense     26 44
Deferred income tax provision/(benefit)     (140) 104
Postemployment benefit plan contributions     (23) (64)
Goodwill and intangible asset impairment losses     1,223 451
Nonmonetary currency devaluation     10 131
Loss/(gain) on sale of business     (490) 15
Other items, net     (34) 20
Trade receivables     138 (2,154)
Inventories     (637) (645)
Accounts payable     113 130
Other current assets     (73) (103)
Other current liabilities     (381) 124
Net cash provided by/(used for) operating activities     1,990 878
Cash receipts on sold receivables     0 1,296
Capital expenditures     (581) (594)
Payments to acquire business, net of cash acquired     (199) (248)
Proceeds from sale of business, net of cash disposed     1,875 18
Proceeds from issuance of long-term debt     2,967 2,990
Other investing activities, net     16 13
Net cash provided by/(used for) investing activities     1,111 485
Repayments of long-term debt     (3,272) (2,706)
Proceeds from issuance of commercial paper     377 2,485
Repayments of commercial paper     (377) (1,950)
Dividends paid     (1,464) (2,421)
Other financing activities, net     (21) (35)
Net cash provided by/(used for) financing activities     (1,881) (1,637)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     (40) (128)
Net increase/(decrease)     1,180 (402)
Balance at beginning of period     1,136 1,769
Balance at end of period $ 2,316 1,367 2,316 1,367
Beneficial interest obtained in exchange for securitized trade receivables     $ 0 938
As Previously Reported        
Consolidated Statements of Cash Flows        
Net income/(loss)   628   2,376
Depreciation and amortization       736
Amortization of postretirement benefit plans prior service costs/(credits)       (261)
Equity award compensation expense       44
Deferred income tax provision/(benefit)       96
Postemployment benefit plan contributions       (64)
Goodwill and intangible asset impairment losses       499
Nonmonetary currency devaluation       131
Loss/(gain) on sale of business       15
Other items, net       21
Trade receivables       (2,154)
Inventories       (663)
Accounts payable       145
Other current assets       (105)
Other current liabilities       83
Net cash provided by/(used for) operating activities       899
Cash receipts on sold receivables       1,296
Capital expenditures       (594)
Payments to acquire business, net of cash acquired       (248)
Proceeds from sale of business, net of cash disposed       18
Proceeds from sale of business, net of cash disposed       18
Proceeds from issuance of long-term debt       2,990
Other investing activities, net       13
Net cash provided by/(used for) investing activities       485
Repayments of long-term debt       (2,727)
Proceeds from issuance of commercial paper       2,485
Repayments of commercial paper       (1,950)
Dividends paid       (2,421)
Other financing activities, net       (35)
Net cash provided by/(used for) financing activities       (1,658)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash       (128)
Net increase/(decrease)       (402)
Balance at beginning of period       1,769
Balance at end of period   1,367   1,367
Beneficial interest obtained in exchange for securitized trade receivables       938
Restatement | Restatement Impacts        
Consolidated Statements of Cash Flows        
Net income/(loss)   (10)   (2)
Depreciation and amortization       (24)
Amortization of postretirement benefit plans prior service costs/(credits)       0
Equity award compensation expense       0
Deferred income tax provision/(benefit)       8
Postemployment benefit plan contributions       0
Goodwill and intangible asset impairment losses       (48)
Nonmonetary currency devaluation       0
Loss/(gain) on sale of business       0
Other items, net       (1)
Trade receivables       0
Inventories       18
Accounts payable       (15)
Other current assets       2
Other current liabilities       41
Net cash provided by/(used for) operating activities       (21)
Cash receipts on sold receivables       0
Capital expenditures       0
Payments to acquire business, net of cash acquired       0
Proceeds from sale of business, net of cash disposed       0
Proceeds from issuance of long-term debt       0
Other investing activities, net       0
Net cash provided by/(used for) investing activities       0
Repayments of long-term debt       21
Proceeds from issuance of commercial paper       0
Repayments of commercial paper       0
Dividends paid       0
Other financing activities, net       0
Net cash provided by/(used for) financing activities       21
Effect of exchange rate changes on cash, cash equivalents, and restricted cash       0
Net increase/(decrease)       0
Balance at beginning of period       0
Balance at end of period   $ 0   0
Beneficial interest obtained in exchange for securitized trade receivables       0
Restatement, Capital Leases | Restatement Impacts        
Consolidated Statements of Cash Flows        
Net cash provided by/(used for) operating activities       (21)
Net cash provided by/(used for) financing activities       (21)
Restatement, Other Misclassifications | Restatement Impacts        
Consolidated Statements of Cash Flows        
Net cash provided by/(used for) operating activities       (1)
Net cash provided by/(used for) financing activities       $ (1)